Literature DB >> 24097117

Reply: 'Central retinal artery occlusion and cerebral stroke'.

A W Lee1, C S Chen2, S Cugati2, D Varma1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24097117      PMCID： PMC3869518          DOI： 10.1038/eye.2013.216

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  9 in total

1.  Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1.

Authors:  N Feltgen; A Neubauer; B Jurklies; C Schmoor; D Schmidt; J Wanke; H Maier-Lenz; M Schumacher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-22       Impact factor: 3.117

2.  Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.

Authors:  Celia S Chen; Andrew W Lee; Bruce Campbell; Tien Lee; Mark Paine; Clare Fraser; John Grigg; Romesh Markus
Journal:  Stroke       Date:  2011-07-14       Impact factor: 7.914

3.  Central retinal artery occlusion and cerebral stroke.

Authors:  D McLeod
Journal:  Eye (Lond)       Date:  2013-10-04       Impact factor: 3.775

Review 4.  A review of central retinal artery occlusion: clinical presentation and management.

Authors:  D D Varma; S Cugati; A W Lee; C S Chen
Journal:  Eye (Lond)       Date:  2013-03-08       Impact factor: 3.775

5.  Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.

Authors:  J Astrup; L Symon; N M Branston; N A Lassen
Journal:  Stroke       Date:  1977 Jan-Feb       Impact factor: 7.914

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  Central retinal artery occlusion. Retinal survival time.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Alan Kimura; Ashish Sanon
Journal:  Exp Eye Res       Date:  2004-03       Impact factor: 3.467

Review 8.  Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.

Authors:  J Donald Easton; Jeffrey L Saver; Gregory W Albers; Mark J Alberts; Seemant Chaturvedi; Edward Feldmann; Thomas S Hatsukami; Randall T Higashida; S Claiborne Johnston; Chelsea S Kidwell; Helmi L Lutsep; Elaine Miller; Ralph L Sacco
Journal:  Stroke       Date:  2009-05-07       Impact factor: 7.914

9.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.